Skip to main content
SpringerLink
Log in

Titration of natural and disease-related cytotoxicity of lymphocytes from bladder cancer patients

Correlation with the tumor classification

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

A controlled investigation of lymphocyte-mediated cytotoxicity has been carried out in patients with transitional cell carcinoma (TCC) of the urinary bladder, three long-term established cell lines with comparable sensitivities to the natural cytotoxicity (NC) being used as targets, namely HU 456 derived from human TCC, HU 609 from normal human urothelium, and SAOS 2 from a human osteosarcoma. The 44-h incubation microcytotoxicity assay (MA) was used with ‘blinded’ semiautomatic visual counting of target cells. The cytotoxicity was determined by titration with a serial dilution of lymphocyte suspensions 1:2, five different concentrations being used in each experiment. Fifty tests were performed with lymphocytes from 48 TCC patients. As controls, 65 patients with diseases other than TCC were tested simultaneously. The average cytotoxicity of lymphocytes from TCC patients against HU 456 was only slightly and insignificantly higher than that of the control patients. However, a marked decrease of the NC against the control cells HU 609 and SAOS 2 was noted with TCC patient lymphocytes.

After correction of the data for the depression of background NC, increased tumor-specific cytotoxicity (TSC) and tumor type-specific cytotoxicity (TTSC) were demonstrated in TCC patients with noninvasive malignant tumors (grade 2 or 3), whereas no increased specific cytotoxicity was found in TCC patients with invasive grade 2 or 3 tumors. Neither was any increased specific cytotoxicity found in patients with very well-differentiated grade tumors. The presence of specific reactivity in patients with noninvasive TCC in contrast to invasive TCC is supposed to indicate growth-controlling function of the cellular immune reaction.

Tests were also performed with lymphocytes from 35 patients in the postoperative phase without any history of TCC. Surprisingly, this group revealed a significantly elevated TSC but not increased TTSC when compared with the 65 untreated control patients, thus indicating that serious reservations must be made in the interpretation of the cytotoxocity assay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Akira D, Takasugi M (1977) Loss of specific natural cell-mediated cytotoxicity with absorption of natural antibodies from serum. Int J Cancer 19:747

    Google Scholar 

  2. Bean MA, Pees H, Fogh JE, Grabstald H, Oettgen HF (1974) Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder. Detection by a 3H-proline microcytotoxicity test. Int J Cancer 14:186

    Google Scholar 

  3. Bergkvist A, Ljungqvist A, Moberger G (1965) Classification of bladder tumors based on the cellular pattern. Acta Chir Scand 130:371

    Google Scholar 

  4. Bloom ET, Seeger RC (1976) Disease and non-disease-related cell-mediated cytotoxicity in humans. Cancer Res 36:1361

    Google Scholar 

  5. Bloom ET, Ossorio RC, Brosman SA (1974) Cell-mediated cytotoxicity against human bladder cancer. Int J Cancer 14:326

    Google Scholar 

  6. Brown JP, Belle G van, Hellström I (1976) Design of experiments using the microcytotoxicity assay. Int J Cancer 18:230

    Google Scholar 

  7. Bubenik J, Perlmann P, Helmstein K, Moberger G (1970) Immune response to urinary bladder tumors in man. Int J Cancer 5:39

    Google Scholar 

  8. Catalona WJ, Oldham RK, Herberman RB, Djeu JY, Cannon GB (1977) Lack of specificity of lymphocyte-mediated cytotoxicity against the bladder cancer cell line, T 24. J Urol 118:254

    Google Scholar 

  9. De Vries JE, Rümke P (1976) Tumor-associated lymphocyte cytotoxicity superimposed on ‘spontaneous’ cytotoxicity in melanoma patients. Int J Cancer 17:182

    Google Scholar 

  10. Dickmeiss E, Soeberg B, Svejgaard A (1977) Human cell-mediated cytotoxicity against modified target cells is restricted by HLA. Nature 270:526

    Google Scholar 

  11. Doherty PC, Götze D, Trinchieri G, Zinkernagel RM (1976) Models for recognition of virally modified cells by immune thymus-derived lymphocytes. Immunogenetics 3:517

    Google Scholar 

  12. Fujimoto S, Matsuzawa T, Nakagawa K, Tada T (1978) Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse. Cell Immunol 38:378

    Google Scholar 

  13. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ (1977) Yantigen killing by T cells of women is restricted by HLA. Nature 266:544

    Google Scholar 

  14. Hakala TR, Lange PH, Castro A, Elliott A, Fraley EE (1974) Cell-mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract. Cancer 34:1929

    Google Scholar 

  15. Hellström I, Hellström KE, Sjörgen HO, Warner GA (1971) Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer 7:1

    Google Scholar 

  16. Jerrells TR, Dean JH, Richardson GL, McCoy JL, Herberman RB (1978) Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients. J Natl Cancer Inst 61:1001

    Google Scholar 

  17. Kristensen E, Langvad E (1978) Natural cytotoxicity. Cancer Immunol Immunother 5:71

    Google Scholar 

  18. Kristensen E, Reimann R (1977) Direct cytotoxicity test applied to patients in stage I and II of malignant skin melanoma. Cancer Immunol Immunother 2:49

    Google Scholar 

  19. Levy NL (1978) Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors. J Immunol 121:903

    Google Scholar 

  20. Moore M, Robinson N (1977) Cell-mediated cytotoxicity in carcinoma of the human urinary bladder. Cancer Immunol Immunother 2:233

    Google Scholar 

  21. O'Toole C, Perlmann P, Unsgaard B, Moberger G, Edsmyr F (1972a) Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Int J Cancer 10:77

    Google Scholar 

  22. O'Toole C, Perlmann P, Unsgaard B, Almg»rd LE, Johansson B, Moberger G, Edsmyr F (1972b) Cellular immunity to human urinary bladder carcinoma. II. Effect of surgery and preoperative irradiation. Int J Cancer 10:92

    Google Scholar 

  23. Pross HF, Baines MG (1976) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. I. The effect of malignant disease. Int J Cancer 18:593

    Google Scholar 

  24. Takasugi M, Mickey MR, Terasaki PI (1973) Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res 33:2898

    CAS  PubMed  Google Scholar 

  25. Takasugi M, Koide Y, Akira D, Ramseyer A (1977) Specificities in natural cell-mediated cytotoxicity by the cross-competition assay. Int J Cancer 19:291

    Google Scholar 

  26. Trinchieri G, Aden DP, Knowles BB (1976) Cell-mediated cytotoxicity to SV 40-specific tumor-associated antigens. Nature 261:312

    Google Scholar 

  27. Troye M, Perlmann P, Larsson Å, Blomgren H, Johansson B (1977) Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay. Int J Cancer 20:188

    Google Scholar 

  28. Troye M, Vilien M, Pape GR, Perlmann P (1980) Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or antologous tumor cells derived from established cell lines or short-term cultures. Int J Cancer 25:33

    Google Scholar 

  29. Vanky F, Klein E, Stjernsward J, Rodrigues L, Peterffy A, Steiner L, Nilsonne U (1978) Human tumor-lymphocyte interaction in vitro. III. T lymphocytes in autologous tumor stimulation (ATS). Int J Cancer 22:679

    Google Scholar 

  30. Vilien M, Wolf H (1978) The specificity of the microcytotoxicity assay for cell-mediated immunity in human bladder cancer. J Urol 119:338

    Google Scholar 

  31. Yu A, Watts H, Jaffe N, Parkman R (1977) Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma. N Engl J Med 297:121

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Fibiger Laboratory, Nordre Friahvnsgade 70, DK-2100, Copenhagen Ø, Denmark

    M. Vilien

  2. Department of Urology, Hvidovre Hospital, Copenhagen, Denmark

    H. Wolf

  3. Department of Urology, Københavns Amtssygehus, Herlev, Denmark

    F. Rasmussen

Authors
  1. M. Vilien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Rasmussen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vilien, M., Wolf, H. & Rasmussen, F. Titration of natural and disease-related cytotoxicity of lymphocytes from bladder cancer patients. Cancer Immunol Immunother 8, 189–195 (1980). https://doi.org/10.1007/BF00205671

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205671

Keywords

Search

Navigation